The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues.
作者信息
Gong Wenping, An Huiru, Wang Jie, Cheng Peng, Qi Yong
机构信息
Tuberculosis Prevention and Control Key Laboratory, Senior Department of Tuberculosis, The 8th Medical Center of People's Liberation Army (PLA) General Hospital, Beijing, China.
Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of People's Liberation Army (PLA) General Hospital, Beijing, China.
出版信息
Front Immunol. 2022 Jul 8;13:953228. doi: 10.3389/fimmu.2022.953228. eCollection 2022.
Abstract
摘要
相似文献
1
The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues.卡介苗接种对新冠病毒病的自然影响：争论仍在继续。
Front Immunol. 2022 Jul 8;13:953228. doi: 10.3389/fimmu.2022.953228. eCollection 2022.
2
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?牛分枝杆菌卡介苗（BCG）疫苗的多样性及接种前景：为何BCG无法预防结核病？
Vaccine. 2015 Sep 22;33(39):5035-41. doi: 10.1016/j.vaccine.2015.08.033. Epub 2015 Aug 28.
3
Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.卡介苗接种对结核分枝杆菌和气溶胶攻击的牛分枝杆菌的保护效果比较。
Clin Infect Dis. 2000 Jun;30 Suppl 3:S299-301. doi: 10.1086/313878.
4
Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.小鼠原发性肺结核后的免疫反应：结核分枝杆菌和卡介苗诱导同等程度的保护作用。
J Infect Dis. 2004 Aug 1;190(3):588-97. doi: 10.1086/422394. Epub 2004 Jul 6.
5
Protective immunity against tuberculosis in a free-living badger population vaccinated orally with Mycobacterium bovis Bacille Calmette-Guérin.在自由生活的獾群中口服牛分枝杆菌卡介苗后对结核病的保护性免疫。
Transbound Emerg Dis. 2022 Jul;69(4):e10-e19. doi: 10.1111/tbed.14254. Epub 2021 Aug 13.
6
Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.在卡介苗接种前通过使CD4(+)CD25(+)调节性T细胞失活来加速二次免疫反应并不能增强对结核病的保护作用。
Eur J Immunol. 2008 Mar;38(3):695-705. doi: 10.1002/eji.200737888.
7
Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.经皮接种牛型结核分枝杆菌卡介苗加速结核分枝杆菌感染肺部中分枝杆菌抗原特异性 CD8+T 细胞的诱导。
Immunology. 2009 Dec;128(4):556-63. doi: 10.1111/j.1365-2567.2009.03141.x.
8
Disseminated Bacille Calmette-Guerin (BCG) disease in an infant with severe combined immunodeficiency.一名患有严重联合免疫缺陷的婴儿发生播散性卡介苗（BCG）病。
J Coll Physicians Surg Pak. 2014 Nov;24 Suppl 3:S259-61.
9
Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin.接种不同菌株卡介苗的婴儿独特的基因表达谱。
Infect Immun. 2007 Jul;75(7):3658-64. doi: 10.1128/IAI.00244-07. Epub 2007 May 14.
10
Vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis bacille Calmette-Guérin (BCG) results in positive tuberculin skin test results in a dose-dependent fashion.给白尾鹿（Odocoileus virginianus）接种牛分枝杆菌卡介苗（BCG）会导致结核菌素皮试结果呈剂量依赖性阳性。
Res Vet Sci. 2020 Apr;129:70-73. doi: 10.1016/j.rvsc.2020.01.010. Epub 2020 Jan 11.
引用本文的文献
1
Recombinant BCG-Based HIV Vaccine: Failures and Promising Approaches for a Successful Vaccine Strategy.基于重组卡介苗的HIV疫苗：成功疫苗策略的失败与前景方法
Vaccines (Basel). 2025 Jun 3;13(6):606. doi: 10.3390/vaccines13060606.
2
Efficacy of Bacille Calmette-Guérin Against COVID-19 Hospitalisation: A Meta-Analysis and Systematic Review of Randomised Control Trials.卡介苗预防新型冠状病毒肺炎住院治疗的疗效：一项随机对照试验的荟萃分析和系统评价
Vaccines (Basel). 2025 Mar 4;13(3):267. doi: 10.3390/vaccines13030267.
3
BCG Vaccination-Associated Lower HbA1c and Increased CD25 Expression on CD8 T Cells in Patients with Type 1 Diabetes in Ghana.加纳1型糖尿病患者中，卡介苗接种与较低的糖化血红蛋白A1c及CD8 T细胞上CD25表达增加相关。
Vaccines (Basel). 2024 Apr 24;12(5):452. doi: 10.3390/vaccines12050452.
4
Designing Anti-Viral Vaccines that Harness Intrastructural Help from Prior BCG Vaccination.设计利用先前卡介苗接种提供的结构内辅助作用的抗病毒疫苗。
J Cell Immunol. 2023;5(4):97-102. doi: 10.33696/immunology.5.174.
5
Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19.在设计评估卡介苗对新冠病毒病影响的临床试验时，有两个问题需要注意。
Front Immunol. 2023 May 23;14:1207212. doi: 10.3389/fimmu.2023.1207212. eCollection 2023.
6
PP19128R, a Multiepitope Vaccine Designed to Prevent Latent Tuberculosis Infection, Induced Immune Responses and Assays.PP19128R，一种旨在预防潜伏性结核感染的多表位疫苗，诱导的免疫反应及检测方法。
Vaccines (Basel). 2023 Apr 17;11(4):856. doi: 10.3390/vaccines11040856.
7
A Summary on Tuberculosis Vaccine Development-Where to Go?结核病疫苗研发总结——路在何方？
J Pers Med. 2023 Feb 24;13(3):408. doi: 10.3390/jpm13030408.
8
Over 90% of Childhood BCG Vaccine-Induced Keloids in Japan Occur in Women.在日本，超过90%的儿童卡介苗接种后所致瘢痕疙瘩发生在女性身上。
Dermatol Ther (Heidelb). 2023 May;13(5):1137-1147. doi: 10.1007/s13555-023-00916-0. Epub 2023 Mar 23.
9
Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB.新型结核疫苗候选物 HP13138PB 的生物信息学分析和一致性验证。
Front Immunol. 2023 Jan 27;14:1102578. doi: 10.3389/fimmu.2023.1102578. eCollection 2023.
10
Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19.BCG 对 COVID-19 的特异性和非特异性免疫作用及其保护作用的研究进展。
Front Immunol. 2023 Jan 31;14:1118378. doi: 10.3389/fimmu.2023.1118378. eCollection 2023.
本文引用的文献
1
ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.ACTIVATE-2：一项针对 COVID-19 高危人群的卡介苗疫苗接种的双盲随机临床试验。
Front Immunol. 2022 Jul 5;13:873067. doi: 10.3389/fimmu.2022.873067. eCollection 2022.
2
The Potential Roles of BCG Vaccine in the Prevention or Treatment of COVID-19.BCG 疫苗在预防或治疗 COVID-19 中的潜在作用。
Front Biosci (Landmark Ed). 2022 May 13;27(5):157. doi: 10.31083/j.fbl2705157.
3
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.SARS-CoV-2 变体和 COVID-19 疫苗：当前的挑战与未来策略。
Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28.
4
BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.BCG 疫苗接种：对抗 COVID-19 和类似 COVID-19 的黑天鹅事件的潜在工具。
Int Immunopharmacol. 2022 Jul;108:108870. doi: 10.1016/j.intimp.2022.108870. Epub 2022 May 17.
5
Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial.卡介苗再接种对医护人员新冠发病率的安全性和有效性：一项双盲、随机、对照、3期试验。
EClinicalMedicine. 2022 Jun;48:101414. doi: 10.1016/j.eclinm.2022.101414. Epub 2022 May 12.
6
Efficacy and Safety of BCG Revaccination With BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial.BCG 莫斯科复种预防医护人员 COVID-19 感染的疗效和安全性：一项随机 II 期临床试验。
Front Immunol. 2022 Mar 22;13:841868. doi: 10.3389/fimmu.2022.841868. eCollection 2022.
7
Trained Immunity: An Overview and the Impact on COVID-19.训练免疫：概述及对 COVID-19 的影响。
Front Immunol. 2022 Feb 17;13:837524. doi: 10.3389/fimmu.2022.837524. eCollection 2022.
8
A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland-First Results.一项多中心、随机、双盲、安慰剂对照的III期临床试验，评估在波兰新冠疫情期间，对有症状的医护人员进行卡介苗再接种对SARS-CoV-2感染发生率和严重程度的影响——初步结果
Vaccines (Basel). 2022 Feb 17;10(2):314. doi: 10.3390/vaccines10020314.
9
COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity.基于重组病毒和细菌载体系统的 COVID-19 疫苗开发：适应性和训练免疫的协同作用。
J Microbiol. 2022 Mar;60(3):321-334. doi: 10.1007/s12275-022-1621-2. Epub 2022 Feb 14.
10
Association of Calmette Guerin Vaccine Strains with COVID-19 Morbidity and Mortality - Evaluation of Global Data.卡介苗菌株与新冠发病率和死亡率的关联——全球数据评估
Indian J Community Med. 2021 Oct-Dec;46(4):727-730. doi: 10.4103/ijcm.IJCM_103_21. Epub 2021 Dec 8.
Zotero 插件